IL10 and hepatocellular carcinoma: Previous studies have shown that the anti-inflammatory IL10 was overexpressed in both intratumoral and peritumoral hepatic tissues of HCC patients,37 and has delivered multiple tumor-promoting functions in both areas of the liver.